Comparison of intact antibody structures and the implications for effector function

Advances in Immunology

Volumn , Issue 72, 1999, Pages 191-208

  Harris, Lisa J ^a   Larson, Steven B ^a   Mcpherson, Alexander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FC RECEPTOR; INTERCELLULAR ADHESION MOLECULE 2; MONOCLONAL ANTIBODY; PARAPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN RECOGNITION; CRYSTAL STRUCTURE; DENDRITIC CELL; HUMAN; LYMPHOCYTE HOMING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION;

ANTIBODIES; ANTIBODY SPECIFICITY; IMMUNE SYSTEM; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033501383     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2776(08)60021-8     Document Type: Article

References (65)

1. Braden, B. C., and Poljak, R. J. (1995). Stnictural features of the reactions between antibodies and protein antigens. Fascb J. 9, 9-16.
2. Brekke, O. IL, Micliaelsen, T. E., Sandin, R., and Sandlie, I. (1993). Activation of complement by an IgG molecule without a genetic hinge. Nature 363, 628-630.
3. Brekke, O. IL, Micliaelsen, T. E., Aase, A., Sandin, R., and Sandlie, I. (1994). Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis. Eur. J. Immunol. 24, 2542-2547.
4. Brekke, O. IL, Micliaelsen, T. E., and Sandlie, I. (1995). The structural requirements for complement activation by IgG: Does it hinge on the hinge? Immunol. Today 16, 85-90.
5. Brekke, O. IL, Micliaelsen, T. E., Sandin, R., and Sandlie, I. (1996). Activation of complement by an IgG molecule without a genetic hinge [published erratum]. Nature 383, 103.
6. Burmeister, W. P., Huber, A. IL, and Bjorkman, P. J. (1994). Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372, 379-383.
7. Burton, D. R. (1990a). Antibody: The flexible adaptor molecule. Trends Biocliem. Sei. 15, 65-69.
8. Burton, D. R. (1990b). The conformation of antibodies. In "Fc Receptors and the Action of Antibodies" (H. Metzger, ed.), pp. 31-54. American Society for Microbiology, Washington D.C.
9. Burton, D. R., and Woof, J. M. (1992). Human antibody effector function. Ado. Immunol. 51, 1-84.
10. Canfield, S. M., and Morrison, S. L. (1991). The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the Cn2 domain and is modulated by the hinge region.J. Exp. Med. 173, 1483-1491.
11. Clackson, T., and Winter, G. (19S9). Sticky feet-directed mutagenesis and its application to swapping antibody domains. Nucleic Acids Res. 17, 10163-10170.
12. Cohnan, P. M. (19S8). Structure of antibody-antigen complexes: Implications for immune recognition. Adv. Immunol. 43, 99-132.
13. Corper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., and Sutton, B. J. (1997). Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struct. Biol. 4, 374-381.
14. Dangl, J. L., Wensel, T. G., Morrison, S. L., Stryer, L., Herzenberg, L. A., and Oi, V. T. (1988). Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO ]. 7, 19S9-1994.
15. Davies, D. R., and Chacko, S. (1993). Antibody structure. Ace. Chem. Res. 26, 421-427.
16. Davies, D. R., and Cohen, G. H. (1996). Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sei. U.S.A. 93, 7-12.
17. Deisenhofer, J. (1981). Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococciis aurais at 2.9- and 2.8-A resolution. Biochemistry 20, 2361-2370.
18. Derrick, J. P., and Wigley, D. B. (1992). Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature 359, 752-754.
19. Dorrington, K. J. (1978). The structural basis for the functional versatility of immunoglobulin Gl. Can. J. Biochem. 56, 1087-1101.
20. Dunean, A. R., and Winter, G. (19S8). The binding site for Clq on IgG. Nature 332,738-740.
21. Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R., and Winter, G. (1988). Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332, 563-564.
22. Edmundson, A. B., Wood, M. K., Schiffer, M., Hardman, K. D., Ainsworth, C. F., Ely, K. R., and Deutsch, H. F. (1970). A Crystallographic investigation of a human IgG immunoglobulin. J. Biol. Chem. 245, 2763-2764.
23. Edmundson, A. B., Guddat, L. W., Rosauer, R. A., Andersen, K. N., Shan, L., and Fan, Z.-C. (1995). Three-dimensional aspects of IgG structure and function. 7;i "The Antibodies" (M. Zanetti and J. D. Capra, eds.), pp. 41-100. Harwood Academic Publishers, New
24. York, New York. Ely, K. R., Colman, P. M., Abola, E. E., Hess, A. C., Peabody, D. S., Parr, D. M., Connell, G. E., Laschinger, C. A., and Edmundson, A. B. (1978). Mobile Fc region in the Zie IgG2 cryoglobulin: Comparison of crystals of the F(ab')2 fragment and the intact immunoglobulin. Biochemistry 17, 820-823.
25. Furukawa, K., and Kobata, A. (1991). IgG galactosylation-Its biological significance and pathology. Mol. Immunol. 28, 1333-1340.
26. Ghetie, V., and Ward, E. S. (1995). Genetic manipulation of antibodies: From variable domains to constant regions. In "The Antibodies" (M. Zanetti and J. D. Capra, eds.), pp. 169-211. Hanvood Academic Publishers, New York, New York.
27. Greenwood, J., Clark, M., and Waldmann, II. (1993). Structural motifs involved in human IgG antibody effector functions. Eur. ]. Immilnol. 23, 1098-1104.
28. Guddat, L. W., Herron, J. N., and Edmundson, A. B. (1993). Three-dimensional structure of a human immunoglobulin with a hinge deletion. Proc. Natl. Acad. Sei. U.S.A. 90,4271-4275.
29. Harris, L. J., Larson, S. B., Hasel, K. W., Day, J., Greenwood, A., and McPherson, A. (1992). The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature 360, 369-372.
30. Harris, L. J., Skaletsky, E., and McPherson, A. (1995). Crystallization of intact monoclonal antibodies. Proteins: Struct. Funct. Genet. 23, 285-289.
31. Harris, L. J., Larson, S. B., Hasel, K. W., and McPherson, A. (1997). Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1581-1597.
32. Harris, L. J., Larson, S. B., Skaletsky, E., and McPherson, A. (1998). Comparison of the conformations of two intact monoclonal antibodies with hinges. Immunological Reviews 163, 35-43.
33. Harris, L. J., Skaletsky, E., and McPherson, A. (1998). Crystallographic structure of an intact IgGl monoclonal antibody.J. Mol. Biol. 275, 861-872.
34. Kabat, E. A., Wu, T. T., Perry, II. M., Gottesman, K. S., and Foeller, C. (1991). In "Sequences of Proteins of Immunological Interest," 5th Ed. U.S. Public Health Service, NIH, Washington, D.C.
35. Kastern, W., Holst, E., Nielsen, E., Sjöbring, U., and Björck, L. (1990). Protein L, a bacterial immunoglobulin-binding protein is a possible virulence factor. Infect. Immun. 58, 1217-1222.
36. Klein, M., Haeffner-Cavaillon, N., Isenman, D. E., Rivat, C., Navia, M. A., Davies, D. R., and Dorrington, K. J. (1981). Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc. Natl. Acad. Sei. U.S.A. 78, 524-528.
37. Larson, S., Day, J., Greenwood, A., Skaletsky, E., and McPherson, A. (1991). Characterization of crystals of an intact monoclonal antibody for canine lymphoma.J. Mol. Biol. 222,17-19.
38. Lund, J., Winter, G., Jones, P. T., Pound, J. D., Tanaka, T., Walker, M. R., Artymiuk, P. J., Arata, Y., Burton, D. R., Jefferis, R., and Woof, J. M. (1991). Human FcyRI and FcyRII interact with distinct but overlapping sites on human IgG. J. Immunol. 147, 2657-2662.
39. Lund, J., Pound, J. D., Jones, P. T., Duncan, A. R., Bentley, T., Goodall, M., Levine, B. A., Jefferis, R., and Winter, G. (1992). Multiple binding sites on the C,2 domain of IgG for mouse FcyRI 1. Mol. Immunol. 29, 53-59.
40. Marquart, M., Deisenhofer, J., Huber, R., and Palm, W. (19SO). Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.9 A resolution.J. Mol. Biol. 141, 369-391.
41. Metzger, II. (1978). The effect of antigen on antibodies: Recent studies. 7;i "Contemporary Topics in Molecular Immunology" (R. A. Reisfeld and F. P. Inman, eds.), pp. 119-152. Plenum, New York. Michaelsen, T. E., Brekke, O. H., Aase, A., Sandin, R. H., Bremnes, B., and Sandlie, I. (1994). One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge. Proc. Natl. Acad. Sci. U.S.A. 91, 9243-9247.
42. Morgan, A., Jones, N. D., Nesbitt, A. M., Chaplin, L., Bodmer, M. W., and Emtage, J. S. (1995). The N-terminal end of the Cn2 domain of chimeric human IgGl anti-HLA-DR is necessary for Clq, FcyRI and FcyRIII binding. Immunology 86, 319-324.
43. Nose, M., and Wigzell, H. (19S3). Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl. Acad. Sei. U.S.A. 80, 6632-6636.
44. Oi, V. T., Vuong, T. M., Hardy, R., Reidler, J., Dangle, J., Herzenberg, L. A., and Stryer, L. (1984). Correlation between segmental flexibility and effector function of antibodies. Nature 307, 136-140.
45. Padlan, E. A. (1996). X-Ray crystallography of antibodies. In "Advances in Protein Chemistry, Antigen Binding Molecules: Antibodies and T-cell Receptors" (E. Haber, ed.), Vol. 49, pp. 57-133. Academic Press, New York.
46. Palm, W., and Colman, P. M. (1974). Preliminary X-ray data from well-ordered crystals of a human immunoglobulin G molecule. J. Mol. Biol. 82, 587-588.
47. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanwortb, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., Takeuchi, F., Nagano, Y., Miyamoto, T., and Kobata, A. (19S5). Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316, 452-457.
48. Raeder, R., and Boyle, M. D. P. (1993). Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect. Immun. 61, 3696-3702.
49. Roux, K. H. (1984). Direct demonstration of multiple VU allotopes on rabbit Ig molecules: Allotope characteristics and Fab arm rotational flexibility revealed by immunoelectron I microscopy. Etir. J. Imiminol. 14, 459-464.
50. Sarma, R., and Laudin, A. G. (1982). The three-dimensional structure of a human IgGl immunoglobulin at 4 A resolution: A computer fit of various structural domains on the electron density map. J. Appl. Crystallogr. 15, 476-481.
51. Sarmay, G., Lund, J., Rozsnayay, Z., Gergely, J., and Jefferis, R. (1992). Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc receptors. Mol, Immunol. 29, 633.
52. Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlen, M., and Jones, T. A. (1995). Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure 3, 265-278.
53. Sheriff, S. (1993). Antibody-protein complexes. ImmtinoMcthods 3, 222-227.
54. Silverton, E. W., Navia, M. A., and Davies, D. R. (1977). Three-dimensional structure of an intact human immunoglobulin. Proc. Nail. Acacl. Sei. U.S.A. 74, 5140-5144.
55. Steiner, L. A., and Lopes, A. D. (1979). The crystallizable human myeloma protein Dob has a hinge-region deletion. Biochemistry 18, 4054-4067.
56. Stura, E. A., Satterthwait, A. C., Calvo, J. C., Stefanko, R. S., Langeveld, J. P., and Kaslow, D. C. (1994). Crystallization of an intact monoclonal antibody (4B7) against Plasmodium falcipantm malaria with peptides from the Pfs25 protein antigen. Acta Cnjstallogr. D50, 556-562.
57. Tao, M. II., Canfield, S. M., and Morrison, S. L. (1991). The differential ability of human IgGl and IgG4 to activate complement is determined by the COOII-terminal sequence of the C,2 domain./ Exp. Mcd. 173, 1025-1028.
58. Tao, M. II., Smith, R. I. F., and Morrison, S. L. (1993). Structural features of human immunoglobulin G that determines isotype-specific differences in complement activation. J. Exp. Med. 178, 661-667.
59. Terry, W. D., Matthews, B. W., and Davies, D. R. (1968). Crystallographic studies of a human immunoglobulin. Nature 220, 239-241.
60. Tsuchiya, N., Endo, T., Matsuta, K., Yoshinoya, S., Aikawa, T., Kosuge, E., Takeuchi, F., Miyamoto, T., and Kobata, A. (19S9). Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. BJietimatol. 16, 285-290.
61. Utsumi, S., Okada, M., Udaka, K., and Amano, T. (19S5). Preparation and biologic characterization of fragments containing dimeric and monomeric C gamma 2 domain of rabbit IgG. Mol. Imiminol. 22, 811-819.
62. Vaughn, D. E., Milbum, C. M., Penny, D. M., Martin, W.-L., Johnson, J. L., and Bjorkman, P. J. (1997). Identification of critical IgG binding epitopes on the neonatal Fc receptor. J. Mol. Biol. 274, 597-607.
63. Wade, R. IL, Taveau, J. C., and Lamy, J. N. (1989). Concerning the axial rotational flexibility of tlie Fab regions of immunoglobulin G. J. Mol. Biol. 206, 349-356.
64. Wilson, I. A., and Stanfield, R. L. (1994). Antibody-antigen interactions: New structures and new conformational changes. Curr. Opin. Struct. Biol. 4, 857-867.
65. Wrigley, N. G., Brown, E. B., and Skehel, J. J. (1983). Electron microscopic evidence for the axial rotation and inter-domain flexibility of the Fab regions of immunoglobulin G. J. Mol. Biol. 169, 771-774.